Home > National Drug Code (NDC) > ERYTHROMYCIN

ERYTHROMYCIN - 16590-088-20 - (ERYTHROMYCIN)

Alphabetical Index


Drug Information of ERYTHROMYCIN

Product NDC: 16590-088
Proprietary Name: ERYTHROMYCIN
Non Proprietary Name: ERYTHROMYCIN
Active Ingredient(s): 250    mg/1 & nbsp;   ERYTHROMYCIN
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of ERYTHROMYCIN

Product NDC: 16590-088
Labeler Name: Stat Rx USA
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA062746
Marketing Category: ANDA
Start Marketing Date: 19861222

Package Information of ERYTHROMYCIN

Package NDC: 16590-088-20
Package Description: 20 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16590-088-20)

NDC Information of ERYTHROMYCIN

NDC Code 16590-088-20
Proprietary Name ERYTHROMYCIN
Package Description 20 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16590-088-20)
Product NDC 16590-088
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ERYTHROMYCIN
Dosage Form Name CAPSULE, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 19861222
Marketing Category Name ANDA
Labeler Name Stat Rx USA
Substance Name ERYTHROMYCIN
Strength Number 250
Strength Unit mg/1
Pharmaceutical Classes Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient]

Complete Information of ERYTHROMYCIN


General Information